The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.
April 18th 2024
Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Therapeutic Advances in Plaque Psoriasis to Address Unmet Needs in Treatment and Improve Patient Outcomes
1.5 Credits / Dermatology
View More
Managed Care Considerations for Management of Molluscum Contagiosum: Examining Emerging Treatments
1.0 Credit / Dermatology
View More
AJMC® Powered by Patients and Managed Care Insights – More Than a Cosmetic Disease: Vitiligo Treatment Approaches and Raising Awareness of the Disease Burden
1.5 Credits / Dermatology
View More
Treatment With TNF Inhibitors Does Not Reduce Risk of Developing Psoriatic Arthritis After Psoriasis
June 19th 2020In 90% of patients, psoriasis precedes psoriatic arthritis by an average of 7 years, providing a window of opportunity for early intervention and possible prevention of psoriatic arthritis.
Read More
Immunosuppressive Psoriatic Drugs Don't Increase Risks for COVID-19 Complications
June 13th 2020Authors of an opinion piece concluded that not only are immunosuppressed patients with psoriasis not at an increased risk of developing serious complications related to coronavirus disease 2019 (COVID-19), their medications may help mitigate potential issues.
Read More
What Is the Impact of Psoriasis on Patients' Mental Health?
June 12th 2020Patients with psoriasis often have other physical diseases, and these somatic comorbidities can have a bigger effect on the patient’s mental health than the skin symptoms from their psoriasis, according to a study published in JAMA Dermatology.
Read More
Examining the Prevalence of Obesity and Depression Among Patients With Psoriasis on Biologics
May 30th 2020Use of biologics to treat psoriasis may impact prevalence of comorbidities like depression and obesity, according to an abstract presented at the Virtual 2020 International Society for Pharmacoeconomics and Outcomes Research meeting.
Read More
Gap Remains in Identifying Patients With Psoriasis Likely to Develop Psoriatic Arthritis
May 29th 2020Despite some clues, scientists don’t yet understand which patients with psoriasis are likely to eventually develop psoriatic arthritis; solving that riddle could have major impacts on patient care.
Read More
Sociodemographic Factors Influence Outcomes Among Patients With Psoriasis
May 22nd 2020A patient’s sex, disease duration, and residence were the most common sociodemographic factors shown to affect illness acceptance, life satisfaction, sense of stigmatization, and quality of life among those who have psoriasis, according to the results of a recent study.
Read More
Virtual ISPOR Panel to Examine Next Steps in Value Assessment
May 18th 2020Two of the panelists appearing during the Virtual ISPOR 2020 meeting preview what's needed in improving value assessment: Lou Garrison, PhD, of the University of Washington, and Leah Howard, JD, of the National Psoriasis Foundation.
Read More
Case Report Describes Immunotherapy for Patient With Psoriasis, HIV-Negative Kaposi Sarcoma
May 16th 2020Some oncologists refrain from prescribing checkpoint immunotherapy in patients with Kaposi sarcoma who also have psoriasis or other skin conditions. A new case report says the therapy can be successfully completed while still controlling the skin condition.
Read More
Platelet Abnormalities Play Role in CVD in Patients With Psoriasis, Report Says
May 15th 2020Platelet function may aid in determining disease severity for patients with psoriasis who are at an increased risk of developing cardiovascular disease (CVD) and increased inflammation, a review notes.
Read More
Psoriasis Guidelines From AAD, NPF Spotlight Comorbidities
May 8th 2020Guidelines created by the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) address care management and treatment options for patients with psoriasis in relation to the increased risk of developing inflammatory, cardiovascular, and metabolic conditions.
Read More
Genetics of Psoriatic Arthritis Remains a Complicated Puzzle, Researchers Say
April 24th 2020A number of advances have been made in recent years in our understanding of the genetics of psoriatic diseases and psoriatic arthritis specifically. However, those advances have yet to translate into clinically meaningful insights.
Read More
Psoriasis Linked to Higher Risk of Alzheimer Disease, Researchers Find
April 19th 2020Psoriasis typically emerges among the young, while Alzheimer disease is mainly a disorder of old age, raising the question of whether psoriasis has an impact on the later development of neurodegenerative diseases.
Read More
Immune Checkpoint Inhibitors Linked With Psoriasis Flare-ups in Rare Cases
February 17th 2020Patients undergoing immunotherapy could be at risk for psoriasis flare-ups, even if the patient is asymptomatic at the initiation of cancer treatment. A newly published case report outlines a rare case where immunotherapy had to be stopped due to severe skin lesions.
Read More
Dose Reduction of Biologics to Treat Psoriasis Exhibits Inferior Efficacy to Normal Dose
February 12th 2020Dose reduction of biologics adalimumab, etanercept, and ustekinumab was not shown to be as effective as providing the usual doses for treatment of psoriasis, according to study findings published today.
Read More